Navigation Links
Growth in Medical Technology

TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men

... DC VA Medical Center, tests the effects of growth hormone (GH) therapy, both combined with sex ... extremely unusual to analyze the effect of both growth hormone and sex steroids," said Harman. ... studied extensively. The body naturally secretes growth hormones to ...

Is Your Hair Taking a Break?

... on the head for a shorter time due to a short growth phase, resulting in baby fine hairs that do not ... not grow new hair, it works by prolonging the growth phase of hair -- providing more time for hair to ... you want to keep that is not reaching its maximum growth and is an easy way to fill in hair density," said ...

Risks of Delaying ACL Reconstruction in Young Athletes May Be Too High, Study Shows

... under the age of 14. "The risk of inducing a growth disturbance with early reconstruction of a torn ... and fixation devices that did not cross the growth plate. Patients were also followed for a minimum of one-year post-operatively with no growth disturbances being noted. "In our study, the ...

HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study

... onto the wound surface, it is thought that growth promoting and healing signals will be generated ... and a cell preparation containing a mixture of growth arrested, living, allogeneic epidermal ... studies, HP802-247 is expected to release various growth and angiogenic factors into the microenvironment ...

CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders

... --Orally Active Enhancer of Human Nerve growth Factor Has Demonstrated Promising Activity ... active agent that enhances the effects of nerve growth factor (NGF). CeNeRx intends to initiate a Phase ... neuropathy (CIPN) later this year. "Nerve growth factor has long been of interest as a potential ...

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

... to placebo, more than doubled time without tumor growth (15.6 months vs. 5.9 months) and reduced the risk ... AUY922 exceeded the level needed to inhibit tumor growth in a mouse model for breast cancer(14). ... reduces and in many cases can control growth hormone and/or normalize IGF-1 levels in patients ...

Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009

... lung cancer (NSCLC) patients who have epidermal growth factor receptor (EGFR) mutations.(2) "Lung ... irreversible dual inhibitor of the epidermal growth factor receptor (EGFR) and human epithelial ... by simultaneously inhibiting vascular endothelial growth factor receptors (VEGFRs), ...

Spherix Reports First Quarter 2009 Earnings

... health sciences segment. Strong growth from health sciences consulting services. ... "We are pleased with the excellent growth of our health sciences consulting business," ... The Company's revenue improvement reflects the growth of its health sciences consulting services ...

Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers

... locally stimulate the release of platelet-derived growth factor-B protein (PDGF-B), an important key in ... subsidiary (TRC) is focused on the development of growth factor therapeutics for the treatment of severe ... delivery carrier encoding human platelet-derived growth factor-B (PDGF-B). Excellarate(TM) is initially ...

Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion

... "ischemic" (starved for oxygen), resulting in the growth of abnormal new blood vessels that can cause ... biology of CRVO is related to edema and the growth of abnormal new blood vessels that are mediated by vascular endothelial growth factor (VEGF), we are hopeful that VEGF Trap-Eye ...

Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrine's Fully Human Anti-PS Antibody in Prostate Cancer Model

... Equivalent to the Human Antibody Inhibited Tumor growth in a Prostate Cancer Model by More than 90%- ... antibody of PGN635 significantly retarded the growth of tumors by more than 90%. These positive ... anti-phosphatidylserine antibody inhibits the growth of prostate cancer in mice. In: Proceedings of ...

Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib

... - Afinitor more than doubled time without tumor growth and reduced the risk of disease progression or ... controls tumor cell division and blood vessel growth - Phase III trials underway to explore ... placebo, more than doubled the time without tumor growth or death in patients with advanced kidney cancer ...

Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack

... will lead to local production of insulin-like growth factor-1 protein to enhance this process and ... developing a portfolio of innovative DNA-based growth factor therapeutics for cardiovascular and ... subsidiary (TRC) is focused on the development of growth factor therapeutics for the treatment of severe ...

Another LNA-based RNA Inhibitor Enters Clinical Trials

... Survivin is a key protein that controls cancer growth by playing a significant role in cell division, ... SN-38 drug conjugate, markedly inhibits tumor growth and metastatic spreading of human neuroblastoma" ... specifically inhibits the growth of AR-positive tumor cells" "The antitumor ...

Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers

... and a cell preparation containing a mixture of growth arrested, living, allogeneic epidermal ... studies, HP802-247 is expected to release various growth and angiogenic factors into the micro-environment ... surface in a thin fibrin matrix. The secreted growth and angiogenic factors are anticipated to ...

Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology

... subsidiary (TRC) is focused on the development of growth factor therapeutics for the treatment of severe ... delivery carrier encoding human platelet-derived growth factor-BB (PDGF-BB). Excellarate(TM) is ... tadenovec, Ad5FGF-4) is a DNA-based growth factor therapeutic developed for potential use by ...

American Academy Of Orthopaedic Surgeons 2009 Annual Meeting 'Highlights and Hot Topics'

... Diagnosis There is little bone growth or development after a person reaches the mid-20s ... bone and soft tissue health are now surfacing. growth factor combinations such as bone morphogenetic protein, platelet rich plasma, and platelet derived growth factor and other potential therapeutic agents are ...

Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance

... in 2007 to develop ARX201, Ambrx's long-acting growth hormone product, currently in Phase II of ... ideally suited to harness the potential of our growth hormone and multiple sclerosis product candidates ... product candidate, ARX201, is a long-acting human growth hormone drug candidate partnered with Merck ...

Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody

... in anti-angiogenesis and significant tumor growth inhibition in MCF-7 and MX-1 breast cancer ... Lactadherin has a critical role in promoting the growth of new blood vessels to support tumor growth through the activation of VEGF-mediated ...

Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP

... the safety of hGH-CTP, its long-acting human growth hormone (hGH), as well as to provide preliminary ... a dose that was 1,040 times the daily dose of growth hormone recommended for use in human patients. ... proprietary long-acting version of human growth hormone. hGH is used for the long-term treatment ...

New Study First to Confirm Sandostatin LAR(R) Depot Controls Tumor Growth in Patients With Rare Gastrointestinal Tumors

... LAR more than doubled time without tumor growth for a median of 14 months compared to six months ... on findings that Sandostatin LAR halted tumor growth in 69% of patients, compared with 39% of patients ... that Sandostatin LAR also helps control tumor growth in patients with metastatic neuroendocrine tumors ...

OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications

... for Wounds, Diabetic Foot Ulcers and Hair growth Using Nano-Materials with Angiogenic Properties ... for wound healing, diabetic foot ulcers and hair growth are being developed by the company, with plans to ... of wound healing, diabetic foot ulcers and hair growth are underway. Clinical trials are anticipated to ...

Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology

... About Leukine Leukine is a growth factor that helps fight infection and disease in ... HealthCare Pharmaceuticals. Leukine is the only growth factor approved in the U.S. for use following ... its indications, Leukine is the only myeloid growth factor approved to reduce the incidence of ...

New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria

... than imipenem and ertapenem, and inhibited growth of CIPRE and ESBLE at very low drug ... -- Doripenem, imipenem and ertapenem, inhibited growth of >90% of ESBLE at concentrations of 0.25 ... doripenem, imipenem and ertapenem inhibited the growth of >90% of CIPRE at concentrations of 0.5 ...

Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium

... Nedd8 Activating Enzyme (NAE) in tumor growth and survival. It is a first-in-class small ... Growth Factor Receptor / Human Epidermal growth Factor Receptor (EGFR/HER) and Vascular Endothelial growth Factor/Platelet ...

Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy

... in Non-Small Cell Lung Cancer Inhibits Tumor growth and Increases Efficacy of Chemotherapy," reports ... Suppression of Nrf2 effectively inhibited tumor growth and increased sensitivity to chemotherapeutic ... of therapeutics that target Nrf2 to inhibit tumor growth and circumvent chemoresistance." Quark ...

Protein Shown to Play a Key Role in Normal Development of Nervous System

... for the neurotransmitter glutamate, promotes the growth of dendrites, both in nerve cell cultures and in ... signals into the cell. The most vigorous dendrite growth occurs shortly after birth, when GluR1 is present ... with another protein, SAP97, to control dendrite growth during the early postnatal period. "Our ...

Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial

... we have seen a moderation in our U.S. sales growth during the second fiscal quarter ending September 30. While we still expect solid U.S. sales growth over the previous fiscal year, we do not expect to reach the sales growth forecast we have provided for the fiscal year. We ...

Eating Walnuts Slows Cancer Growth, Laboratory Study Finds

... -- Snack-sized quantities of walnuts slow cancer growth in mice, reports a Marshall University ... diet. "When we fed the mice the walnuts, the growth rate of the tumors they had was dramatically ... very good to find something that will slow the growth of tumors without being toxic chemotherapy," said ...

Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig

... its management energies on intracompany sales growth as well. The Company also announced that it has ... Europe, continue to provide significant growth opportunities," commented Dr. David Ginsberg, the ... countries. We also intend to expand and focus our growth efforts in additional therapeutic areas as well. ...

Latest RAD001 Study Results Show Further Increase in Time Without Tumor Growth in Patients With Advanced Kidney Cancer

... data, updated since ASCO, show time without tumor growth now reaches nearly 5 months with RAD001 ... show that patients receiving RAD001 had no tumor growth for nearly 5 months vs. 1.9 months for patients ... of patients and societies. Focused solely on growth areas in healthcare, Novartis offers ...

RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors

... suspension) and RAD001 given alone control tumor growth in patients with pancreatic neuroendocrine ... even more potent than somatostatin at inhibiting growth hormone, glucagon and insulin. Based on these ... of patients and societies. Focused solely on growth areas in healthcare, Novartis offers ...

RAD001 Granted Priority Review in the US Based on Potential to Fill Unmet Medical Need in Patients With Advanced Kidney Cancer

... that RAD001 more than doubles time without tumor growth and reduced risk of disease progression by ... RAD001 more than doubled time without tumor growth and reduced the risk of disease progression ... of patients and societies. Focused solely on growth areas in healthcare, Novartis offers ...

Cardium Reports on Second Quarter 2008 Highlights and Financial Results

... Ad5FGF-4), is a DNA-based growth factor therapeutic being developed for potential ... a one-time treatment to promote and stimulate the growth of collateral circulation in the hearts of ... company focused on the development of growth factor therapeutics for the treatment of severe ...

Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities

... Ad5FGF4), is a DNA-based growth factor therapeutic being developed for potential ... a one-time treatment to promote and stimulate the growth of collateral circulation in the hearts of ... company focused on the development of growth factor therapeutics for the treatment of severe ...

Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters

... Inc. today announced it has initiated a corporate growth plan with the appointment of Abbie Celniker, ... to working with her as we implement our corporate growth plan to build a company focused on ... is expected to enable Taligen to implement its growth plan and advance multiple product candidates to ...

Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models

... Xenograft PC3 results -- Tumor volume growth suppressed significantly. Tumor volume ... Xenograft Du145luc results -- Tumor volume growth unaffected by combination treatment, as expected. ... unlike the HA-producing PC3 tumors, tumor growth curves in the control and the PEGPH20 groups were ...

Modigene Platform Validated in Independent Phase III Trial of CTP Technology

... to extend the duration of action of human growth hormone and interferon beta, with the goal of ... of Modigene's CTP-enhanced versions of human growth hormone and interferon beta that we intend to ... fertility trial ever conducted. Human growth hormone (hGH), which is used to ...

Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO'08

... are finding tremendous opportunities for growth in Kansas," Smilor said. "It's not just the ... initiative created by the Kansas Economic growth Act of 2004 to expand the state's ... capacity and bioscience clusters; support the growth of bioscience startups; and stimulate bioscience ...

Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta

... role of estrogen receptor beta in breast cancer growth regulation. The data, which were presented at the ... gene via the estrogen receptor beta results in growth arrest. "Breast cancer is the most common ... activation of important genes that stimulate the growth of cancer cells. This pathway might be an ...
Other Contents
(Date:8/28/2014)... A unique method for delivering compounds that ... HIV and AIDS may be possible, thanks ... Agricultural Sciences., A semi-soft vaginal suppository made ... loaded with the antiviral drug Tenofovir provides ... against the spread of sexually transmitted infections ...
(Date:8/28/2014)... Dyslexia, the most commonly diagnosed learning disability ... disability that occurs when the regions of the ... , The use of non-invasive functional neuroimaging tools ... in dyslexia. However, most prior work has focused ... leaving a gap in our understanding of how ...
(Date:8/28/2014)... person to alert the world to Global Warming, has ... and stored underground. He says that Carbon Capture, combined ... way to avoid global warming getting out of control ... New York) made the call during his presentation to ... scientists are meeting to discuss Carbon Capture and Storage. ...
Breaking Biology News(10 mins):Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3Dyslexic readers have disrupted network connections in the brain 2Global warming pioneer calls for CO2 to be taken from atmosphere and stored underground 2
(Date:8/30/2014)... 30, 2014 "My wife suffered neck, ... car accident," said one of two inventors from Bethel, ... her shoulder and neck area. She tried other pillows ... and pressure, assisting in comfort and providing extra sleep." ... CRADLE to support the head, neck and back comfortably. ...
(Date:8/30/2014)... 30, 2014 Market Research Report ... is a professional and in-depth market survey on ... firstly reviews the basic information of Lab Oven ... report then explores global and China’s top manufacturers ... production value, and market share etc. , The ...
(Date:8/30/2014)... Serving contented clients since inception, #1 ... Outsourcing is now offering discount for Labor Day ... emphasize on putting forward the best of web development ... dedicated team of professionals and web developers and designers ... even the critical issues of web development and can ...
(Date:8/30/2014)... August 30, 2014 The federal ... lawsuits ( http://www.injurybeacon.com/transvaginal-mesh/ ) filed against Boston Scientific ... four cases selected for one of the proceeding’s ... August 18, 2014, U.S. District Judge Joseph R. ... disagrees with Boston Scientific’s contention that a consolidated ...
(Date:8/30/2014)... Spain Saturday 30 August 2014: Transvenous lead extraction ... cases according to data from the European Lead Extraction ... at ESC Congress 2014 by Dr Maria Grazia Bongiorni, ... said: "The number of cardiac implantable electronic devices (CIED) ... in technology the number of complications has increased and ...
Breaking Medicine News(10 mins):Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Profit By Outsourcing Offering Discount for Labor Day on all Web Development Services 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3Health News:Transvenous lead extraction clinically successful in 98 percent of cases 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 3
Other TagsOther Tags